Who Exports Combiflam from India — 42 Suppliers Behind a $24.3K Market
India's combiflam export market is supplied by 42 active exporters who collectively shipped $24.3K across 174 shipments. CAPSTONE EXPORT & IMPORT leads with a 21.0% market share, followed by VEA IMPEX (I) PRIVATE LIMITED and SHAURYA INTERNATIONAL. The top 5 suppliers together control 49.1% of total export value, reflecting a moderately competitive market structure.
Top Combiflam Exporters from India — Ranked by Export Value
CAPSTONE EXPORT & IMPORT is the leading combiflam exporter from India, holding a 21.0% share of the $24.3K market across 174 shipments from 42 exporters. The top 5 suppliers — CAPSTONE EXPORT & IMPORT, VEA IMPEX (I) PRIVATE LIMITED, SHAURYA INTERNATIONAL, NAMAN GLOBAL IMPEX PRIVATE LIMITED, N CHIMANLAL ENTERPRISES — collectively control 49.1% of total export value, indicating a competitive market. Individual shares are: CAPSTONE EXPORT & IMPORT (21.0%), VEA IMPEX (I) PRIVATE LIMITED (9.1%), SHAURYA INTERNATIONAL (8.2%), NAMAN GLOBAL IMPEX PRIVATE LIMITED (6.6%), N CHIMANLAL ENTERPRISES (4.2%).
Top Combiflam Exporters from India
Ranked by export value · 42 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | CAPSTONE EXPORT & IMPORT COMBIFLAM TABSCOMBIFLAM TABS 20'S | $5.1K | 1 | 21.0% |
| 2 | VEA IMPEX (I) PRIVATE LIMITED COMBIFLAM TABSCOMBIFLAM TABS 20'SCOMBIFLAM SUSP (IBUPROFEN PARACE | $2.2K | 4 | 9.1% |
| 3 | SHAURYA INTERNATIONAL COMBIFLAM TABLETCOMBIFLAM TABLETSPHARMACEUTICAL PRODUCTS | $2.0K | 1 | 8.2% |
| 4 | NAMAN GLOBAL IMPEX PRIVATE LIMITED COMBIFLAM TABSCOMBIFLAM TABS 20'S | $1.6K | 1 | 6.6% |
| 5 | N CHIMANLAL ENTERPRISES COMBIFLAM TABSCOMBIFLAM TAB 1BOX [780 TAB]COMBIFLAM TABLET | $1.0K | 2 | 4.2% |
| 6 | JINDAL MEDICAL STORE COMBIFLAM TABLETCOMBIFLAM TABLETSPHARMACEUTICAL PRODUCTSCOMBIFLAM TABLETSPHARMACEUTICALS PRODUCT | $1.0K | 2 | 4.2% |
Related Analysis
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Combiflam sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs). The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. Its advanced R&D infrastructure and institutions like the National Institute of Pharmaceutical Education and Research (NIPER) contribute to its prominence. This robust ecosystem makes Hyderabad a strategic location for sourcing APIs essential for formulations like Combiflam.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with companies such as Zydus Cadila and Torrent Pharmaceuticals headquartered here. The region's strong support infrastructure, including ports and transportation networks, facilitates efficient manufacturing and distribution of finished pharmaceutical products like Combiflam.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceuticals. Mumbai, being India's financial capital, offers extensive port facilities and a well-established logistics network. This region's strategic location ensures seamless export operations, making it instrumental in distributing products like Combiflam to international markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth has been significantly influenced by favorable government policies and tax incentives, attracting numerous pharmaceutical companies. Baddi's prominence underscores its role in the production and distribution of pharmaceutical products.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different pharmaceutical clusters to mitigate risks associated with regional disruptions.
- Leverage Regional Strengths: Source APIs from Hyderabad for their quality and cost-effectiveness, while utilizing Ahmedabad-Vadodara for efficient formulation manufacturing.
- Optimize Logistics: Utilize the Mumbai-Thane-Raigad region's export infrastructure to streamline international distribution channels.
- Monitor Regulatory Compliance: Stay updated with the Central Drugs Standard Control Organisation (CDSCO) guidelines to ensure all sourced products meet quality standards.
By strategically sourcing from these key pharmaceutical clusters, TransData Nexus can enhance the supply chain efficiency and reliability for Combiflam.
Common Questions — Combiflam Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which combiflam supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, CAPSTONE EXPORT & IMPORT leads with 14 recorded shipments worth $5.1K. VEA IMPEX (I) PRIVATE LIMITED (30 shipments) and SHAURYA INTERNATIONAL (3 shipments) are also established high-volume exporters.
Q How many combiflam manufacturers are there in India?
India has 42 active combiflam exporters with a combined export market of $24.3K across 174 shipments to 21 countries. The top 5 suppliers hold 49.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for combiflam from India?
Average FOB unit price: $1.68 per unit, ranging from $0.02 to $40.87. Average shipment value: $140.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 42 verified Indian exporters of Combiflam ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 174 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 21 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
174 Verified Shipments
42 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists